Effects of melatonin and vitamin E on peripheral neuropathic pain in streptozotocin-induced diabetic rats

Iranian Journal of Basic Medical Sciences

Volumn 13, Issue 2 SPRING, 2010, Pages 1-8

  Babaei Balderlou, Farrin ^a   Zare, Samad ^a   Heidari, Reza ^a   Farrokhi, Farah ^a  

^a URMIA UNIVERSITY   (Iran)

Author keywords

Diabetes; Melatonin; Oxidative stress; Pain; Peripheral neuropathy; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; FORMALDEHYDE; GLUTATHIONE PEROXIDASE; MELATONIN; STREPTOZOCIN;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NEUROPATHIC PAIN; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NERVE INJURY; RAT; SPINAL GANGLION; STREPTOZOCIN DIABETES; TREATMENT DURATION; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

EID: 77952768624     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Baynes JW, Thorpe R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48:1-9. (Pubitemid 29019345)
2. Robertson RP. Chronic oxidative stress: a central mechanism for glucose toxicity in pancreatic islet beta cell in diabetes. J Biol Chem 2004; 279:42351-42354. (Pubitemid 39372114)
3. Wolff SP, Dean RT. Glucose auto-oxidation and protein modification. The potential role of antioxidative glycosylation in diabetes. Biochem J 1987; 245:243-250.
4. Klepac N, Rudes Z, Klepac R. Effect of melatonin on plasma oxidative stress in rats with streptozotocin induced diabetes. Biomed Pharmacother 2006; 60:32-35. (Pubitemid 41821216)
5. Serpell M. Anatomy, physiology and pharmacology of pain. Anaesth Intensive Care Med 2005; 6:7-10.
6. Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol 2002; 50:205-228.
7. Morgan PJ, Barrett P, Howell HE, Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994; 24:101-146. (Pubitemid 24061864)
8. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a nerve-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42:28-42.
9. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10. (Pubitemid 36140351)
10. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, et al. Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 2004; 36:1-9. (Pubitemid 38130283)
11. Hong JH, Kim MJ, Park MR, Kwag OG, Lee IS, Byun BH, et al. Effects of vitamin E on oxidative stress and membrane fluidity in brain of streptozotocin-induced diabetic rats. Clin Chim Acta 2004; 340:107-115. (Pubitemid 38167514)
12. Baydas G, Canatan H, Turkoglu A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozotocin-induced diabetes mellitus. J Pineal Res 2002; 32:225-230. (Pubitemid 34478283)
13. Kim HK, Kim JH, Gao X, Zhou JL, Lee I, Chung K, et al. Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain. Pain 2006; 122:53-62.
14. Arreola-Espino R, Urquiza-Marín H, Ambriz-Tututi M, Araiza-Saldaña CI, Caram-Salas NL, Rocha-González HI, et al. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats. Eur J Pharmacol 2007; 577:203-210. (Pubitemid 47632537)
15. Malone JI, Lowitt S, Korthals JK, Salem A, Miranda C. The effect of hyperglycemia on nerve conduction and structure is age dependent. Diabetes 1996; 45:209-215. (Pubitemid 26045804)
16. Tuzcu M, Baydas G. Effects of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol 2006; 537:106-110.
17. Montilla P, Cruz A, Padilla FJ, Tunez I, Gascon F, Munoz MC, et al. Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats. J Pineal Res 2001; 31:138-144. (Pubitemid 32778162)
18. Juarez-Rojop IE, Granados-Soto V, Diaz-Zagoya JC, Flores-Murrieta FJ, Torres-Lopez JE. Involvement of cholecystokinin peripheral nociceptive sensitization during diabetes in rats as revealed by the formalin response. Pain 2006; 122:118-125.
19. Wheeler-Aceto H, Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology 1991; 104:35-44.
20. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4:161-174. (Pubitemid 8234766)
21. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4- hydroxynonenal. Methods Enzymol 1990; 186:407-421. (Pubitemid 20279982)
22. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun 1976; 71:952-958.
23. Aebi H. Catalase in vitro. Method Enzymol 1984; 105:121-126.
24. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193:265-275.
25. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997; 46:38-42.
26. Hawkins CL, Davies MJ. Generation and propagation of radical reactions on proteins. Biochem Biophys Acta 2001; 1504:196-219.
27. Baydas G, Sonkaya E, Tuzcu M, Yasar A, Donder E. Novel role for gabapentin in neuroprotection of central nervous system in streptozotocin- induced diabetic rats. Acta Pharmacol Sin 2005; 26:417-422. (Pubitemid 40477988)
28. Van Dam PS, Van Asbeck BS, Bravenboer B, Van Oirschot JF, Gispen WH, Marx JJ. Nerve function and oxidative stress in diabetic and vitamin E-deficient rats. Free Radic Biol Med 1998; 24:18-26. (Pubitemid 28006432)
29. Halat KM, Dennehy CE. Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy. J Am Board Fam Pract 2003; 16:47-57.
30. Kishi M, Tanabe J, Schmelzer JD, Low PA. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002; 51:819-824. (Pubitemid 34760195)
31. Kishi Y, Nickander KK, Schmelzer JD, Low PA. Gene expression of antioxidant enzymes in experimental diabetic neuropathy. J Peripher Nerv Syst 2000; 5:11-18
32. Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003; 52:165-171.
33. Siu AW, Reiter RJ, To CH. The efficacy of vitamin E and melatonin as antioxidants against lipid peroxidation in rat retinal homogenates. J Pineal Res 1998; 24:239-244.
34. Ziegler D,Gries FA. α-Lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 1997; 46:62-66.
35. Vissers KG, Geenen F, Biermans R, Meert TF. Pharmacological correlation between the formalin test and the neuropathic pain behavior in different species with chronic constriction injury. Pharmcol Biochem Behav 2006; 84:479-486.
36. Sayyed SG, Kumar A, Sharma SS. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sci 2006; 79:777-783.